Brandyn Tyler England, PHARMD | |
1640 S Whitehead Dr, De Witt, AR 72042-2994 | |
(870) 946-2381 | |
Not Available |
Full Name | Brandyn Tyler England |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 1640 S Whitehead Dr, De Witt, Arkansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1720411903 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | PD12301 (Arkansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Brandyn Tyler England, PHARMD 1640 S Whitehead Dr, De Witt, AR 72042-2994 Ph: (870) 946-2381 | Brandyn Tyler England, PHARMD 1640 S Whitehead Dr, De Witt, AR 72042-2994 Ph: (870) 946-2381 |
News Archive
Star Scientific, Inc. announced that on Friday, February 19 the company filed an application with the Food & Drug Administration for approval to market Ariva-BDLâ„¢ as a "modified risk" tobacco product under the Family Smoking Prevention and Tobacco Control Act of 2009. This submission is the first such application to be filed with the Tobacco Products Center of the FDA, which has been established to oversee all aspects of tobacco regulation outlined in the 2009 Act.
According to a Census Bureau announcement this morning, the number of people without health insurance coverage increased from 46.3 million in 2008 to 50.7 million in 2009. Read the Census Bureau's summary of key findings or gain access to the full report here.
The scanR high-content screening (HCS) station version 3.2 delivers improved image quality, better quantitative data, support for challenging segmentation and classification applications and increased speed to help life science researchers maximize the information they get from their samples.
PNP Therapeutics Inc. announced today the Food and Drug Administration has granted orphan drug status to Gedeptin, the Company's lead product candidate (adenoviral vector expressing E. coli purine nucleoside phosphorylase gene) for the intratumoral treatment of anatomically accessible oral and pharyngeal cancers, including cancers of the lip, tongue, gum, floor of mouth, salivary gland and other oral cavities.
Although opioid and heroin deaths have been rising dramatically in the U.S., the magnitude of the epidemic varies from state to state, as does the relative proportion of opioid vs heroin poisonings.
› Verified 6 days ago
Samantha Spicer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1640 S Whitehead Dr, De Witt, AR 72042 Phone: 870-946-2381 | |
Kristi Leigh Whitmore, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 220 Court Sq, De Witt, AR 72042 Phone: 870-946-4221 | |
Howard Dean Watts, P.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1640 S Whitehead Dr, De Witt, AR 72042 Phone: 870-946-2381 Fax: 870-946-4286 | |
Abby Staton, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1640 S Whitehead Dr, De Witt, AR 72042 Phone: 870-946-2381 Fax: 870-946-4286 | |
Tommy Glenn Black, P.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 220 Court Sq, De Witt, AR 72042 Phone: 870-946-4221 Fax: 870-946-1011 | |
Dr. Karen Watts, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1640 S Whitehead Dr, De Witt, AR 72042 Phone: 870-946-2381 Fax: 870-946-4286 | |
Vernon Dewayne Crowell Jr., PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 220 Court Sq, De Witt, AR 72042 Phone: 870-946-4221 |